Einige Inhalte dieser Seite sind nur für Abonnenten sichtbar.       Anmelden     oder      Jetzt abonnieren!

Archiv: Alle Kategorien

Relief Reports that U.S. Collaboration Partner Announced Second Favorable Safety Report for ZYESAMI(TM) (RLF-100TM/aviptadil) in NIH Sponsored ACTIV-3b Critical Care Study in Life-Threatening COVID-19 » Report
Beginn des separaten Handels der Aktien von Sulzer und medmix an SIX Swiss Exchange – medmix gibt endgültigen Angebotspreis von CHF 45 pro neuer medmix-Aktie bekannt, was zu Bruttoerlös von CHF 315 Millionen führt » Report
Sulzer and medmix shares start trading separately on SIX Swiss Exchange – medmix announces final offer price of CHF 45 per new medmix share, resulting in gross proceeds of CHF 315 million » Report
Roche: Phase II/III trial shows Ronapreve™ (casirivimab and imdevimab) significantly reduces viral load within seven days of treatment in patients hospitalised with COVID-19 » Report
HUBER+SUHNER BECOMES SUPPLIER OF RADAR ANTENNAS TO LEADING TIER 1 AUTOMOTIVE SUPPLIER » Report
HUBER+SUHNER WIRD LIEFERANT VON RADARANTENNEN AN FÜHRENDEN TIER-1-AUTOMOBILZULIEFERER » Report
Relief's Subsidiary, APR Applied Pharma Research, Reports Data Published in Journal of Wound Care, Indicating Nexodyn(R) AOS Highly Effective Treatment to Support Healing of Hard-to-Heal Leg Ulcers » Report
Basler Kantonalbank: Raphael Helbling wird neuer Bereichsleiter Legal & Compliance » Report
Dufry extends its Cambodia duty-free concession with three airports for five and a half years. » Report
Dätwyler investiert in profitables Wachstum. » Report
Dätwyler vollzieht den Verkauf des Onlinedistributors Reichelt. » Report
Sweden Repeals Proposal for Chemical Tax on Clothing and Footwear Products
SGS Supports Giving Shoes a Second Life
Digital Explained: Issue 4
Trust SGS Experts for Dislodgeable Foliar Residue (DFR) Crop Trials in Europe » Report
SGS Completes Expansion of Bioanalytical Testing Laboratory in France » Report
Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria » Report
HIAG: Extraordinary General Meeting approves all proposals » Report
HIAG: Ausserordentliche Generalversammlung genehmigt alle Anträge » Report
First Surgery with Medacta's Minimally Invasive M.U.S.T. MC Platform » Report